
Latent Labs makes biology programmable by providing generative AI models that accelerate molecular design for health and sustainability. They build foundational deep learning models and generative AI trained on biological data to design new antibodies, optimize enzymes, and advance genetic engineering. Latent Labs operates as a frontier AI lab serving biotech and pharmaceutical partners with AI-powered molecular design tools and collaborations with cloud and hardware providers. Founded by former DeepMind scientists involved with AlphaFold, the company combines machine learning, deep learning, and generative modeling to address complex molecular problems at scale.

Latent Labs makes biology programmable by providing generative AI models that accelerate molecular design for health and sustainability. They build foundational deep learning models and generative AI trained on biological data to design new antibodies, optimize enzymes, and advance genetic engineering. Latent Labs operates as a frontier AI lab serving biotech and pharmaceutical partners with AI-powered molecular design tools and collaborations with cloud and hardware providers. Founded by former DeepMind scientists involved with AlphaFold, the company combines machine learning, deep learning, and generative modeling to address complex molecular problems at scale.
What they do: Frontier AI lab building generative foundation models to design proteins and biologics
Founded: 2023
Headquarters: London (with San Francisco presence)
Funding: $50M total (seed + Series A)
Founder / CEO: Dr. Simon Kohl
| Company |
|---|
Protein and biologics design; computational molecular biology
2023
Biotechnology
$50M
Structure reported as a previously unannounced $10M seed tranche plus a $40M Series A
βBacked by venture firms (Radical Ventures, Sofinnova Partners, 8VC, Pillar VC, Kindred Capital, Isomer, Flying Fish) and angel investors including Jeff Dean, Aidan Gomez, Mati Staniszewski, and othersβ